{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:52:17Z","timestamp":1775807537399,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1400,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1553-2712.2011.01217.x","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T18:56:18Z","timestamp":1321556178000},"page":"1135-1140","source":"Crossref","is-referenced-by-count":5,"title":["l-Carnitine Increases Survival in a Murine Model of Severe Verapamil Toxicity"],"prefix":"10.1111","volume":"18","author":[{"given":"Eric","family":"Perez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Bania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Medlej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,11,17]]},"reference":[{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0033-0620(97)80037-0","article-title":"Carnitine and its derivatives in cardiovascular disease","volume":"40","author":"Arsenian","year":"1997","journal-title":"Prog Cardiovasc Dis."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1253\/jcj.56.86","article-title":"l-Carnitine treatment for congestive heart failure-experimental and clinical study","volume":"56","author":"Kobayashi","year":"1992","journal-title":"Jpn Circ J."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin Toxicol (Phila)."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB4|cit4","first-page":"250","article-title":"Effect of acetyl-l-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients","volume":"2","author":"Scarpini","year":"1997","journal-title":"J Peripher Nerv Syst."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/00003246-199507000-00016","article-title":"Beneficial myocardial effects of insulin during verapamil toxicity in the anesthetized canine","volume":"23","author":"Kline","year":"1995","journal-title":"Crit Care Med."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13181-010-0072-z","article-title":"Verapamil inhibits the glucose transport activity of Glut-1","volume":"6","author":"Louters","year":"2010","journal-title":"J Med Toxicol."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1553-2712.2008.00088.x","article-title":"Verapamil toxicity dysregulates the phosphatidylinositol 3-kinase pathway","volume":"15","author":"Bechtel","year":"2008","journal-title":"Acad Emerg Med."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1081\/CLT-100102437","article-title":"Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning","volume":"37","author":"Yuan","year":"1999","journal-title":"Clin Tox."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1553-2712.2007.tb01752.x","article-title":"Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline","volume":"14","author":"Bania","year":"2007","journal-title":"Acad Emerg Med."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1553-2712.2008.00259.x","article-title":"Determining the optimal dose of intravenous fat emulsion for the treatment of severe verapamil toxicity in a rodent model","volume":"15","author":"Perez","year":"2008","journal-title":"Acad Emerg Med."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1553-2712.2006.tb01661.x","article-title":"Intralipid prolongs survival in a rat model of verapamil toxicity","volume":"13","author":"Tebbutt","year":"2006","journal-title":"Acad Emerg Med."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.resuscitation.2009.01.023","article-title":"Intravenous fat emulsion therapy for intentional sustained release verapamil overdose","volume":"80","author":"Young","year":"2009","journal-title":"Resuscitation."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/15563650.2010.543906","article-title":"2009 Annual report of the American association of poison control centers\u2019 national poison data system (NPDS): 26th Annual Report","volume":"48","author":"Bronstein","year":"2010","journal-title":"Clin Toxicol (Phila)."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0735-6757(99)90254-1","article-title":"1998 AAPCC Annual Report","volume":"17","author":"Litovitz","year":"1999","journal-title":"Am J Emerg Med."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1016\/j.biochi.2007.10.002","article-title":"Characteristics of l-carnitine import into heart cells","volume":"90","author":"Rigault","year":"2008","journal-title":"Biochimie."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0022-3565(24)35167-5","article-title":"Na+-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxological relevance","volume":"291","author":"Ohahi","year":"1999","journal-title":"J Pharmacol Exp Ther."},{"issue":"6 Suppl","key":"10.1111\/j.1553-2712.2011.01217.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"S1147","DOI":"10.1093\/ajcn\/54.6.1147s","article-title":"Ascorbic acid and carnitine biosynthesis","volume":"54","author":"Rebouche","year":"1991","journal-title":"Am J Clin Nutr."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1476-5381.1987.tb11343.x","article-title":"Direct activation of Ca+ channels by palmitoyl carnitine, a putative endogenous ligand","volume":"92","author":"Spedding","year":"1987","journal-title":"Br J Pharmac."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1476-5381.1989.tb11971.x","article-title":"Interaction of palmitoyl carnitine with calcium antagonists in myocytes","volume":"97","author":"Patmore","year":"1989","journal-title":"Br J Pharmacol."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB20|cit20","first-page":"757P","article-title":"Positive ionotropic effects of palmitoyl carnitine on embryonic chick heart cell aggregates [abstract]","volume":"89","author":"Duncan","year":"1986","journal-title":"Br J Pharmacol."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0021-9258(18)62505-0","article-title":"Reversible inhibition of mitochondrial adenosine diphosphate phosphorylation by long chain acyl coenzyme A esters","volume":"246","author":"Pande","year":"1971","journal-title":"J Biol Chem."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0008-6363(97)00022-9","article-title":"Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines","volume":"34","author":"Kline","year":"1997","journal-title":"Cardiovasc Res."},{"key":"10.1111\/j.1553-2712.2011.01217.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005344-199605000-00015","article-title":"Myocardial metabolism during graded intraportal verapamil infusion in awake dogs","volume":"27","author":"Kline","year":"1996","journal-title":"J Cardiovasc Pharm."}],"container-title":["Academic Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1553-2712.2011.01217.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1553-2712.2011.01217.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T05:37:15Z","timestamp":1741930635000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1553-2712.2011.01217.x"}},"subtitle":["l-CARNITINE INCREASES SURVIVAL IN VERAPAMIL TOXICITY"],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1553-2712.2011.01217.x","relation":{},"ISSN":["1069-6563"],"issn-type":[{"value":"1069-6563","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}